Mesenchymal stem cells (MSCs) represent a population of adult stem cells residing in many
tissues, mainly bone marrow, adipose tissue, and umbilical cord. Due to the safety and …

Opinion statement Owing to the prevalence of heart disease and the lack of effective long-
term solutions for managing cardiac injury, research has turned to cell therapy as a potential …

Importance of the field: Mesenchymal stem cells (MSCs) have the greatest potential for use
in cell-based therapy of human heart diseases, especially in myocardial infarcts. The …

Myocardial infarction (MI) and heart failure (HF) are significant contributors of mortality
worldwide. Mesenchymal stem cells (MSCs) hold a great potential for cardiac regenerative …

Growing cell-based myocardial therapies which could lead to successful myocardial repair
attracts medical interest. Even more intriguing is the observation that MSCs appears to be a …

With the high mortality rate, coronary heart disease (CHD) has currently become a major life-
threatening disease. The main pathological change of myocardial infarction (MI) is the …

Despite recent progress in treatment, coronary heart disease and heart failure are the major
causes of morbidity and mortality in the Western world. Therefore, cell therapy is currently …

Mesenchymal stem cell (MSC) is an intensely studied stem cell type applied for cardiac
repair. For decades, the preclinical researches on animal model and clinical trials have …

Ischemic heart damage usually triggers cardiomyopathological remodeling and fibrosis, thus
promoting the development of heart functional failure. Mesenchymal stem cells (MSCs) are a …

Purpose Cardiac pathologies remain a dominant cause of morbidity and mortality within the
community. The drive to develop therapies capable of repairing damaged heart tissue to …